Advertisement
Research ArticleArticle

Hepatoselective NO-donors, V-PYRRO/NO and V-PROLI/NO in Nonalcoholic Fatty Liver Disease: a Comparison of Anti-Steatotic Effects with the Biotransformation and Pharmacokinetics

Kamil Kus, Maria Walczak, Edyta Maslak, Agnieszka Zakrzewska, Anna Gonciarz-Dytman, Piotr Zabielski, Barbara Sitek, Krystyna Wandzel, Agnieszka Kij, Adrian Chabowski, Ryan J Holland, Joseph E Saavedra, Larry K Keefer and Stefan Chlopicki
Drug Metabolism and Disposition April 20, 2015, dmd.115.063388; DOI: https://doi.org/10.1124/dmd.115.063388
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Hepatoselective NO-donors, V-PYRRO/NO and V-PROLI/NO in Nonalcoholic Fatty Liver Disease: a Comparison of Anti-Steatotic Effects with the Biotransformation and Pharmacokinetics

Kamil Kus, Maria Walczak, Edyta Maslak, Agnieszka Zakrzewska, Anna Gonciarz-Dytman, Piotr Zabielski, Barbara Sitek, Krystyna Wandzel, Agnieszka Kij, Adrian Chabowski, Ryan J Holland, Joseph E Saavedra, Larry K Keefer and Stefan Chlopicki
Drug Metabolism and Disposition April 20, 2015, dmd.115.063388; DOI: https://doi.org/10.1124/dmd.115.063388
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement